IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IκB Kinase ε Is an NFATc1 Kinase that Inhibits T Cell Immune Response

Published:2016-07 Issue:2 Volume:16 Page:405-418
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Zhang Junjie,Feng Hao,Zhao Jun,Feldman Emily R.,Chen Si-Yi,Yuan Weiming,Huang Canhua,Akbari Omid,Tibbetts Scott A.,Feng Pinghui

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference45 articles.

1. Integrative genomic approaches identify IKBKE as a breast cancer oncogene;Boehm;Cell,2007

2. Adaptive immune responses in acute and chronic hepatitis C virus infection;Bowen;Nature,2005

3. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation;Bulek;Nat. Immunol.,2011

4. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells;Cardin;J. Exp. Med.,1996

5. Molecular mechanisms of T cell co-stimulation and co-inhibition;Chen;Nat. Rev. Immunol.,2013

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity;Cell Communication and Signaling;2024-05-27

2. Palmitoylation of KSHV pORF55 is required for Golgi localization and efficient progeny virion production;PLOS Pathogens;2024-04-16

3. Inhibition of P21-activated kinases 1 and 4 synergistically suppress the growth of pancreatic cancer by stimulating anti-tumour immunity;2024-03-11

4. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets;Molecular Medicine;2024-02-03

5. Non-canonical regulation of the reactivation of an oncogenic herpesvirus by the OTUD4-USP7 deubiquitinases;PLOS Pathogens;2024-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3